- Home
- HITI vs FENC Comparison
HITI vs FENC Comparison
Compare HITI & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HITI
- FENC
- Stock Information
- Founded
- HITI 2009
- FENC 1996
- Country
- HITI Canada
- FENC United States
- Employees
- HITI N/A
- FENC N/A
- Industry
- HITI
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HITI
- FENC Health Care
- Exchange
- HITI Nasdaq
- FENC Nasdaq
- Market Cap
- HITI 249.3M
- FENC 156.9M
- IPO Year
- HITI N/A
- FENC 2001
- Fundamental
- Price
- HITI $3.09
- FENC $5.54
- Analyst Decision
- HITI Strong Buy
- FENC Strong Buy
- Analyst Count
- HITI 1
- FENC 2
- Target Price
- HITI $4.50
- FENC $14.00
- AVG Volume (30 Days)
- HITI 641.5K
- FENC 73.5K
- Earning Date
- HITI 03-14-2025
- FENC 11-07-2024
- Dividend Yield
- HITI N/A
- FENC N/A
- EPS Growth
- HITI N/A
- FENC N/A
- EPS
- HITI N/A
- FENC N/A
- Revenue
- HITI $370,017,302.00
- FENC $49,348,000.00
- Revenue This Year
- HITI $7.52
- FENC $170.43
- Revenue Next Year
- HITI $14.03
- FENC $6.70
- P/E Ratio
- HITI N/A
- FENC N/A
- Revenue Growth
- HITI 9.02
- FENC 278.09
- 52 Week Low
- HITI $1.57
- FENC $3.96
- 52 Week High
- HITI $3.62
- FENC $11.49
- Technical
- Relative Strength Index (RSI)
- HITI 48.76
- FENC 40.02
- Support Level
- HITI $3.01
- FENC $5.61
- Resistance Level
- HITI $3.23
- FENC $6.19
- Average True Range (ATR)
- HITI 0.15
- FENC 0.26
- MACD
- HITI -0.02
- FENC -0.10
- Stochastic Oscillator
- HITI 32.14
- FENC 6.42
About HITI High Tide Inc.
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically-integrated company in the Canadian cannabis market with portfolio subsidiaries including RGR Canada Inc., Famous Brandz Inc., Kush West Distribution Inc., Smoker's Corner Ltd., Grasscity.com, Canna Cabana Inc., and KushBar Inc. The firm has established two main segments, retail and wholesale. It generates substantial revenue from retail stores' e-commerce platforms. Geographically it serves Canada, the USA, and other international markets and earns key revenue from domestic sales.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.